OXIS INTERNATIONAL, INC. is one of the oldest biotech companies in the U.S. with operations dating back to 1966.  Our broad focus and expertise makes Oxis well positioned for active participation in three key segments of the Life Sciences Research, In Vitro Diagnostics, and Biopharma markets:  

• BIOMARKERS are substances found in blood and tissues whose presence may indicate a disease state. The ability to detect and measure minute levels of biomarkers is a key in enabling physicians to diagnose diseases earlier and to help researchers study and develop new biopharmaceutical compounds. OXIS and BioCheck have a broad portfolio of assays and reagents for the Life Sciences and Clinical Diagnostics market as well as an active development program for new cardiac disease and cancer products.  We also have extensive expertise in Contract Services – the development and manufacturing of customized biomarker assays and reagents for our Life Sciences Research and Biopharma customers.
  
  

• THERAPEUTICS are the actual remedies that can be used to treat disease. We have several therapeutic compounds that have been or are available to be licensed and include a promising anti-inflammatory in Phase II clinical trials and several therapeutic antioxidant mimics with potential applications in the treatment of neurodegenerative (Alzheimer’s and Parkinson’s), cardiovascular diseases and diabetes.
  
  

• NUTRACEUTICALS are substances that are believed to have a beneficial overall effect on human health and include antioxidants, which have been enjoying growing consumer awareness and association with long-term health benefits. OXIS has patented the synthesis process for L-Ergothioneine, a powerful antioxidant with universal applications in over-the-counter nutraceuticals, and we are currently seeking one or more partners to commercialize this promising asset.